The Biotechnology Industry Organization (BIO) announces today a
discussion, Producing
"21st Century Cures"—2015 U.S. Legislative Outlook, with
U.S. Rep. Fred Upton (R - MI), Chairman of the Committee on Energy and
Commerce, and U.S. Rep. Diana DeGette (D - CO), Chief Deputy Whip, to
take place on February 9, noon to 1 p.m. at the 17th
annual BIO CEO & Investor Conference.
The event, to be held in New York City, February 9-10, 2015, is one of
the largest investor conferences focused on established and emerging
publicly traded and select private biotech companies.
“The biotech industry is eager to answer the call for 21st
Century Cures, led by Chairman Upton and Representative DeGette, to
revolutionize the drug development process and ensure that patients
fully realize the benefits of advancements in biotechnology,” said BIO
President & CEO Jim Greenwood. “This goal can only be realized in an
environment of forward-looking public policies that sustain scientific
discovery and promote biomedical research and investment. I am pleased
to sit down with Chairman Upton and Representative DeGette to discuss
new approaches for expediting the discovery, development and delivery of
breakthrough treatments and cures.”
The conference program will also feature candid, one-on-one
conversations with leading biopharmaceutical executives and analysts,
followed by an interactive question and answer session. The complete
list of Fireside
Chat participants includes:
-
Ian C. Read, Chairman of the Board and CEO, Pfizer
-
Ron Cohen, M.D., President & CEO, Acorda Therapeutics
-
Peter Greenleaf, CEO, Sucampo Pharmaceuticals, Inc.
-
John Maraganore, Ph.D., CEO, Alnylam Pharmaceuticals
-
John F. Milligan, Ph.D., President and COO, Gilead Sciences
To learn more about the BIO CEO & Investor Conference, including
registration, programming and partnering information, please visit here.
The event also provides the opportunity to arrange meetings between
investors, companies and industry business development, licensing and
therapeutic franchise heads. One-on-one meetings will be powered by BIO
One-on-One Partnering™, an interactive environment to
intelligently search, contact and schedule private meetings with
potential partners and investors. This industry-specific, web-based
interactive software enables participants to move efficiently from the
identification of prospective partners to discussion and negotiations.
Complimentary investor
registration is available for those who qualify. For information
regarding qualified investor criteria and to apply for investor
registration, please visit here.
Media
registration is complimentary for credentialed members of the media.
All registrations are subject to verification of credentials.
BIO is pleased to recognize the leadership provided by the BIO CEO &
Investor Conference sponsors including Double Helix Sponsor Merck, Helix
Sponsors Eli Lilly and Pfizer, and Supporting Bank Sponsors BMO Capital
Markets, HC Wainwright & Co., JMP Securities, Lazard and ROTH Capital
Partners, LLC.
About BIO
BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling “innovations transforming our world” and the
BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter.
Upcoming BIO Events
BIO
CEO & Investor Conference
February 9-10, 2015
New York
City, NY
BIO-Europe
Spring
March 9-11, 2015
Paris, France
BIO
Asia International Conference
March 24-25, 2015
Tokyo,
Japan
BioEquity
Europe
May 19-20, 2015
Vienna, Austria
BIO
International Convention
June 15-18, 2015
Philadelphia, PA
Copyright Business Wire 2015